ATLAS Biolabs Participates in Two European Research Projects
News Oct 11, 2012
ATLAS Biolabs has announced its participation in two European research projects focusing on the impact of chromatin dynamics on DNA damage (aDDRess) and the influence of DNA damage on cellular aging (CodeAge).
ATLAS Biolabs will be responsible for the analysis of the NGS data collected in both projects.
This task also includes the development of new strategies and bioinformatics tools for NGS data analysis and the identification of biomarkers of DNA damage.
The DNA in the nuclei of eukaryotic cells is tightly wrapped around histones to form chromatin, a structure subject to constant dynamic changes in the course of DNA replication and DNA repair.
In particular, a better understanding of chromatin dynamics in DNA repair would provide novel insights into the mechanisms by which the cell protects itself from DNA damage and the disturbances that cause human disease.
Moreover, by investigating the cellular responses triggered by DNA damage, it would be possible to find new approaches for preventive therapies and elucidate the process of aging.
Both the aDDRess and CodeAge projects receive funding from the FP7 Marie Curie Initial Training Network of the European Union.
The Training Network opens up career opportunities for young talents and aims to accelerate the transfer of research findings into medical applications by encouraging research collaborations between academic institutions and medium-sized commercial enterprises.
The two projects involve a total of 22 research groups in 9 different European countries.
“aDDRess and CodeAge will combine state-of-the-art knowledge in basic molecular genetics, omics technologies, translational research and clinical application. We are excited about contributing to the analysis of NGS data within both projects,” said Professor Peter Nürnberg, CEO of ATLAS Biolabs GmbH.
Professor Nürnberg continued, “I am convinced that our customers will benefit from the added competencies that we will gather from this program.”
The European research projects aDDRess and CodeAge
aDDRess (chromatin dynamics on the DNA damage response) and CodeAge (Chronic DNA damage in Ageing) are being funded for four years by the Marie Curie Initial Training Networks within the European FP7 program.
The Marie Curie Initial Training Networks are open to young researchers who want to gain experience abroad in the private sector, and to complete their training by participating in a joint European research project.
Discovery Advances Efforts to Prevent Spread of CancerNews
Newly identified gene targets could be key to preventing the spread of cancer, new University of Alberta research has shown.
Streaming Protocol Makes Gene Data Sharing Future-ProofNews
The Large Scale Genomics Work Stream of the Global Alliance for Genomics and Health (GA4GH) has announced eight new implementations of its htsget protocol, a standard released in October 2017 for accessing large-scale genomic sequencing data online that does not depend on file transfers. The protocol and interoperability testing are reported in a paper released online this week in the journal Bioinformatics.
Antiviral Gene Vanquishes ZikaNews
It’s been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying. Now, researchers at Albert Einstein College of Medicine, part of Montefiore, have discovered the secret to the gene’s success: The enzyme it codes for generates a compound that stops viruses from replicating. The newly discovered compound, described in today’s online edition of Nature, offers a novel approach for attacking many disease-causing viruses.